Jeffrey N. Simmons - Mar 1, 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: PRESIDENT, CEO AND DIRECTOR, Director
Signature: /s/ Catherine S. Powell, as Attorney-in-Fact for Jeffrey N. Simmons
Stock symbol: ELAN
Transactions as of: Mar 1, 2023
Transactions value $: -$243,305
Form type: 4
Date filed: 3/3/2023, 08:10 PM
Previous filing: Sep 9, 2022
Next filing: Mar 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Tax liability	-$143K	-12.7K	-1.68%	$11.26	742K	Mar 1, 2023	Direct	F1, F2
transaction	ELAN	Common Stock	Award	$0	+249K	+33.5%	$0.00	991K	Mar 1, 2023	Direct	F3
transaction	ELAN	Common Stock	Tax liability	-$101K	-9.15K	-0.93%	$11.01	975K	Mar 2, 2023	Direct	F1, F4
holding	ELAN	Common Stock						30K	Mar 1, 2023	Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Employee Stock Option (right to buy)	Award	$0	+568K		$0.00	568K	Mar 1, 2023	Common Stock	568K	$11.26	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F2	Includes 2,045 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022.
F3	Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
F4	Balance reflects 7,127 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4.
F5	Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.